Quick highlights
- Supportive IgM antibody marker for cysticercosis evaluation
- Not definitive for active disease; imaging is often required
- Cross-reactivity can occur; clinical context is essential
- No fasting; serum blood test
- Used in selected scenarios based on symptoms and exposure risks
- Positive result does not confirm neurocysticercosis alone
- Negative result may not fully exclude; clinician decides next steps
- Home blood collection available in many service areas
- Clear safety guidance for neurologic red flags
- SEO coverage: cysticercosis IgM test, Taenia solium IgM antibody, neurocysticercosis evaluation
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting required
- Provide symptom timeline and neurologic history to clinician
- Share travel/exposure and sanitation risk factors if relevant
- Collect serum blood sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review with clinician; imaging may be advised
- Seek urgent care for seizures or severe neurologic symptoms
FAQs
It may suggest a recent immune response, but it is not definitive for active infection diagnosis.
No.
No. Imaging and clinical evaluation are central; IgM is supportive.
Yes, cross-reactivity can occur; clinicians interpret with context.
Yes; immune response varies and timing matters.
In selected clinician-directed evaluations based on symptoms and risk factors.
Often same day or within 24 hours.
Serum blood sample.
Yes in many serviceable areas.
Seizures, severe headache, weakness, confusion, or vision changes require urgent evaluation.
Treatment decisions are clinician-led and typically depend on imaging and clinical findings.
CT/MRI, other serology, and specialist evaluation depending on scenario.
Download from <a href='/my-account/'>View reports</a>.
IgM is usually considered more recent, but interpretation varies; clinicians review in context.
Notes
IgM suggests recent infection; confirm clinically.
